Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 04/25/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6546 publications

Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model.

Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model.

Journal: Science translational medicine
Published: April 16, 2025

Corrigendum to "Hyperconnectivity in resting-state fMRI as a marker of disease severity in Myotonic Dystrophy Type 1".

Corrigendum to "Hyperconnectivity in resting-state fMRI as a marker of disease severity in Myotonic Dystrophy Type 1".

Journal: Journal of neuromuscular diseases
Published: April 16, 2025

Drug treatment for myotonia.

Drug treatment for myotonia.

Journal: The Cochrane database of systematic reviews
Published: April 08, 2025

Painful muscle stiffness with markedly elevated serum creatine kinase (CK) levels after twenty weeks of gestation in four patients with myotonic dystrophy type 1 (DM1) and a patient with paramyotonia congenita (PMC).

Painful muscle stiffness with markedly elevated serum creatine kinase (CK) levels after twenty weeks of gestation in four patients with myotonic dystrophy type 1 (DM1) and a patient with paramyotonia congenita (PMC).

Journal: Journal of neuromuscular diseases
Published: March 28, 2025

Antisense RNA therapies for muscular dystrophies.

Antisense RNA therapies for muscular dystrophies.

Journal: Journal of neuromuscular diseases
Published: March 28, 2025

Takotsubo Syndrome in the Setting of Myotonic Dystrophy: A Neurogenic or Mechanically-Triggered Phenomenon?

Takotsubo Syndrome in the Setting of Myotonic Dystrophy: A Neurogenic or Mechanically-Triggered Phenomenon?

Journal: American journal of medical genetics. Part A
Published: March 07, 2025

Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature.

Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature.

Journal: Journal of neuromuscular diseases
Published: March 04, 2025

Newborn screening and rapid genomic diagnosis of neuromuscular diseases.

Newborn screening and rapid genomic diagnosis of neuromuscular diseases.

Journal: Journal of neuromuscular diseases
Published: February 20, 2025

Rehabilitation technology in assessment and treatment of arm and hand function in myotonic dystrophy type 1: A single subject experimental design study.

Rehabilitation technology in assessment and treatment of arm and hand function in myotonic dystrophy type 1: A single subject experimental design study.

Journal: Journal of neuromuscular diseases
Published: February 20, 2025

International collaboration to improve knowledge on myotonic dystrophy type 2.

International collaboration to improve knowledge on myotonic dystrophy type 2.

Journal: Journal of neuromuscular diseases
Published: February 20, 2025

Hyperconnectivity in resting-state fMRI as a marker of disease severity in Myotonic Dystrophy Type 1.

Hyperconnectivity in resting-state fMRI as a marker of disease severity in Myotonic Dystrophy Type 1.

Journal: Journal of neuromuscular diseases
Published: February 20, 2025

Correction: Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study.

Correction: Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study.

Journal: Journal of neurology
Published: February 01, 2025
Showing 1-12 of 6,546

Last Updated: 04/25/2025